To access this element change to forms mode OFF
Grant Award View - GA201485
Super-Responders and Super-Survivors – how to dramatically improve...
GA ID:
GA201485
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$2,609,827.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Super-Responders and Super-Survivors – how to dramatically improve cancer outcomes
Purpose:
Ovarian cancer and other rare cancer types have low survival rates. My program will study women who achieve very long remissions (“Super-Respondersâ€) following PARP inhibitor + immune therapy and “Super-survivorsâ€, individuals who develop three or more cancers. The underlying genetic mechanisms for this are poorly understood. By studying both, we expect to discover key molecular and immune pathways that should underpin effective therapies to prevent cancer recurrence.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009783
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA